Piper Jaffray Upgrades Infinity Pharmaceutical (INFI) to Overweight
Tweet
Share
E-mailGet Alerts INFI Hot Sheet
Price: $0.04 --0%
Rating Summary:
12 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 60
Rating Summary:
12 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 60
Join SI Premium – FREE
Piper Jaffray upgraded Infinity Pharmaceutical (NASDAQ: INFI) from Neutral to Overweight. PT raised from $6 to $9.
For more ratings news on Infinity Pharmaceutical click here and for the rating history of Infinity Pharmaceutical click here.
Shares of Infinity Pharmaceutical closed at $5.79 yesterday.
For more ratings news on Infinity Pharmaceutical click here and for the rating history of Infinity Pharmaceutical click here.
Shares of Infinity Pharmaceutical closed at $5.79 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Upgrades IMCD NV (IMCD:NA) to Buy
- Macquarie Upgrades Muangthai Capital PCL (MTC:TB) to Outperform
- Morgan Stanley Upgrades Indra Sistemas SA (IDR:SM) (ISMAY) to Overweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
